Registrations are now open for the webinar ‘Breaking new ground: Further development to transform diabetes and CKD care’

Led by Professor James Burton, a Professor of Renal Medicine and Honorary Consultant Nephrologist at the University of Leicester, the session will be held on June 24 at 12:30pm.

Diabetes and kidney disease often co-exist with up to 40 per cent of people living with diabetes also having CKD – diabetes remains the most common cause of kidney failure in the UK. Despite a number of new treatments that slow the progression of kidney disease, there is still an unmet need for people living with these linked conditions. This webinar will explore recent advances in the care of people living with diabetes and kidney disease.

Key topics include:

1)  To recap on current guidelines for use of SGLT2i and non-steroidal MRAs in the management of CKD in people living with T2DM

2) To cover new data regarding GLP1-RAs and other emerging treatment strategies

3) Discuss innovative process changes to take every opportunity to optimise the care of people with cardio-renal-metabolic disease

Join us for this exclusive webinar exploring the latest advancements in diabetes and CKD care – don’t miss this chance to stay at the forefront of clinical innovation.

This event is intended for UK HCPs only

AstraZeneca has provided sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia.